FR2257294A1 - - Google Patents

Info

Publication number
FR2257294A1
FR2257294A1 FR7324874A FR7324874A FR2257294A1 FR 2257294 A1 FR2257294 A1 FR 2257294A1 FR 7324874 A FR7324874 A FR 7324874A FR 7324874 A FR7324874 A FR 7324874A FR 2257294 A1 FR2257294 A1 FR 2257294A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7324874A
Other languages
French (fr)
Other versions
FR2257294B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Produits Chimiques Ugine Kuhlmann
Ugine Kuhlmann SA
Original Assignee
Produits Chimiques Ugine Kuhlmann
Ugine Kuhlmann SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE529734D priority Critical patent/BE529734A/xx
Priority to FR1102696D priority patent/FR1102696A/en
Application filed by Produits Chimiques Ugine Kuhlmann, Ugine Kuhlmann SA filed Critical Produits Chimiques Ugine Kuhlmann
Priority to FR7324874A priority patent/FR2257294B1/fr
Priority to NO3260/73A priority patent/NO137205C/en
Priority to LU68263A priority patent/LU68263A1/xx
Priority to BE134751A priority patent/BE803803A/en
Priority to ES418113A priority patent/ES418113A1/en
Priority to CH1213673A priority patent/CH582171A5/xx
Priority to DE19732342880 priority patent/DE2342880A1/en
Priority to JP48100728A priority patent/JPS5849548B2/en
Priority to NLAANVRAGE7312321,A priority patent/NL179257C/en
Priority to GB4286673A priority patent/GB1434544A/en
Priority to MX003804U priority patent/MX2978E/en
Publication of FR2257294A1 publication Critical patent/FR2257294A1/fr
Application granted granted Critical
Publication of FR2257294B1 publication Critical patent/FR2257294B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FR7324874A 1953-06-19 1973-07-06 Expired FR2257294B1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
BE529734D BE529734A (en) 1953-06-19
FR1102696D FR1102696A (en) 1953-06-19 1954-06-17 Power supply device for a consumption circuit
FR7324874A FR2257294B1 (en) 1973-07-06 1973-07-06
NO3260/73A NO137205C (en) 1973-07-06 1973-08-16 ANALOGICAL PROCEDURE FOR THE PREPARATION OF PIPERAZINE PYRIMIDINES WITH THERAPEUTIC EFFECT.
BE134751A BE803803A (en) 1973-07-06 1973-08-20 NEW PIPERAZINO-PYRIMIDINES FOR USE AS MEDICINAL PRODUCTS
LU68263A LU68263A1 (en) 1973-07-06 1973-08-20
ES418113A ES418113A1 (en) 1973-07-06 1973-08-22 Piperazino-pyrimidines process for their preparation and use
CH1213673A CH582171A5 (en) 1973-07-06 1973-08-23
DE19732342880 DE2342880A1 (en) 1973-07-06 1973-08-24 PIPERAZINE-PYRIMIDINE, THE PROCESS FOR THEIR MANUFACTURING AND THEIR USE
JP48100728A JPS5849548B2 (en) 1973-07-06 1973-09-06 Method for producing pyrimidine compound derivatives
NLAANVRAGE7312321,A NL179257C (en) 1953-06-19 1973-09-07 PROCESS FOR PREPARING A MEDICINAL PRODUCT CONTAINING AS 4-PIPERAZINYLPYRIMIDINE DERIVATIVE AS AN ACTIVE COMPOUND AND PROCESS FOR PREPARING ACTIVE COMPOUNDS TO BE USED THEREOF
GB4286673A GB1434544A (en) 1973-07-06 1973-09-12 Piperazino-pyrimidines process for their preparation and use
MX003804U MX2978E (en) 1973-07-06 1973-11-08 PROCEDURE FOR THE PREPARATION OF SUBSTITUTED DERIVATIVES OF PIPERAZINE 5 - METHYL OR 5 - METHYL THYR PIRIMIDINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7324874A FR2257294B1 (en) 1973-07-06 1973-07-06

Publications (2)

Publication Number Publication Date
FR2257294A1 true FR2257294A1 (en) 1975-08-08
FR2257294B1 FR2257294B1 (en) 1977-07-01

Family

ID=9122191

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7324874A Expired FR2257294B1 (en) 1953-06-19 1973-07-06

Country Status (10)

Country Link
JP (1) JPS5849548B2 (en)
BE (1) BE803803A (en)
CH (1) CH582171A5 (en)
DE (1) DE2342880A1 (en)
ES (1) ES418113A1 (en)
FR (1) FR2257294B1 (en)
GB (1) GB1434544A (en)
LU (1) LU68263A1 (en)
MX (1) MX2978E (en)
NO (1) NO137205C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063509A1 (en) * 1981-04-07 1982-10-27 Pharmuka Laboratoires 2-Piperazino-pyrimidine derivatives, processes for their preparation, medicaments containing them and their use as intermediates in the manufacture of medicaments

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605319A (en) * 1975-05-23 1976-11-25 Mar Pha Etu Expl Marques PROCESS FOR PREPARING A MEDICINAL PRODUCT, SUCH MEDICINAL PRODUCT AND PROCESS FOR PREPARING SUITABLE MEDICINAL COMPOUNDS.
FR2417507A2 (en) * 1977-07-28 1979-09-14 Ugine Kuhlmann DIAMINO-2,4 (OR -4,6) METHYLTHIO-5 PYRIMIDINES HERBICIDES
JPS54159877A (en) * 1978-06-07 1979-12-18 Matsushita Electronics Corp Detection method for semiconductor substrate position and break
JPS6177335A (en) * 1984-09-25 1986-04-19 Kazumichi Kimura Defective mark detector for semiconductor pellet
IT1191845B (en) * 1986-01-20 1988-03-23 Dompe Farmaceutici Spa PHARMACOLOGICALLY ACTIVE ALCHYLOLS
JPH02114936U (en) * 1989-03-03 1990-09-14

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063509A1 (en) * 1981-04-07 1982-10-27 Pharmuka Laboratoires 2-Piperazino-pyrimidine derivatives, processes for their preparation, medicaments containing them and their use as intermediates in the manufacture of medicaments
US4535080A (en) * 1981-04-07 1985-08-13 Pharmuka Laboratoires Derivatives of 2-piperazino-pyrimidine, methods for their preparation and their utilization as drugs or intermediates for drugs

Also Published As

Publication number Publication date
FR2257294B1 (en) 1977-07-01
JPS5849548B2 (en) 1983-11-05
GB1434544A (en) 1976-05-05
BE803803A (en) 1974-02-20
ES418113A1 (en) 1976-03-16
CH582171A5 (en) 1976-11-30
DE2342880A1 (en) 1975-01-30
NO137205B (en) 1977-10-10
NO326073L (en) 1975-02-03
JPS5025578A (en) 1975-03-18
MX2978E (en) 1980-01-17
NO137205C (en) 1978-01-18
LU68263A1 (en) 1973-10-24

Similar Documents

Publication Publication Date Title
AU476761B2 (en)
AU474593B2 (en)
AU474511B2 (en)
AU474838B2 (en)
AU476714B2 (en)
FR2257294B1 (en)
AU476696B2 (en)
AU472848B2 (en)
AU477823B2 (en)
AR200256A1 (en)
AU476873B1 (en)
AU477824B2 (en)
BG20963A1 (en)
BG20139A1 (en)
AU479539A (en)
AU479522A (en)
AU479521A (en)
AU479504A (en)
AU479496A (en)
AU479458A (en)
AU479453A (en)
AU479422A (en)
AU479420A (en)
BG19264A1 (en)
AU479419A (en)

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name
TP Transmission of property
ST Notification of lapse